Incidence of cancer in the general population and in patients with or without atopic dermatitis in the U.K.

British Journal of Dermatology

Volumn 163, Issue 5, 2010, Pages 1036-1043

  Arana, A ^a   Wentworth, C E ^b   Fernandez Vidaurre C ^c   Schlienger, R G ^c   Conde, E ^d,e   Arellano, F M ^a,b  

^a Risk Management Resources   (Spain)

^b Risk Management Resources   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

^d HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^e UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

Atopic dermatitis; Cancer; Cohort studies; Epidemiology; Incidence; Lymphoma

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; CALCULATION; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PATIENT; CHILD; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; FEMALE; FOLLOW UP; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; POPULATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SKIN CANCER; UNITED KINGDOM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; NEOPLASMS; RISK FACTORS; YOUNG ADULT;

EID: 78249273300     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09887.x     Document Type: Article

References (32)

1. Fleming S, Bodner C, Devereaux G, et al. An application of the United Kingdom working party diagnostic criteria for atopic dermatitis in Scottish infants. J Invest Dermatol 2001; 117: 1526 -30.
2. Williams H, Robertson C, Stewart A, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood. J Allergy Clin Immunol 1999; 103: 125 -38.
3. McWhorter WP,. Allergy and risk of cancer. A prospective study using NHANES I followup data. Cancer 1988; 62: 451 -5.
4. Sverson RK, Davis S, Thomas DB, et al. Acute myelocytic leukemia and prior allergies. J Clin Epidemiol 1989; 42: 995 -1001.
5. Eriksson NE, Holmén A, Högstedt A, et al. A prospective study of cancer incidence in a cohort examined for allergy. Allergy 1995; 50: 718 -22.
6. Talbot-Smith A, Fritschi L, Divitini ML, et al. Allergy, atopy, and cancer: a prospective study of the 1981 Busselton cohort. Am J Epidemiol 2003; 157: 606 -12.
7. Holly EA, Bracci PM,. Population-based study of non-Hodgkin lymphoma, histology, and medical history among human immunodeficiency virus-negative participants in San Francisco. Am J Epidemiol 2003; 158: 316 -27.
8. Söderberg KC, Hagmar L, Schwartzbaum J, Feychting M,. Allergic conditions and risk of hematological malignancies in adults: a cohort study. BMC Public Health 2004; 4: 51.
9. Ming ME, Levy R, Hoffstad MA, et al. The lack of relationship between atopic dermatitis and nonmelanoma skin cancers. J Am Acad Dermatol 2004; 50: 357 -62.
10. Wang H, Diepgen PL,. Atopic dermatitis and cancer risk. Br J Dermatol 2006; 154: 205 -10.
11. Lewis JD, Schinnar R, Bilker QB, et al. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf 2007; 16: 393 -401.
12. Rothman KJ,. Epidemiology, an Introduction. New York: Oxford University Press, 2002.
13. Ferlay J, Bray F, Pisani P, Parkin DM,. GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base no. 5, version 2.0. Lyon: IARC Press, 2004.
14. Hall HI, Jamison P, Fulton JP, et al. Reporting of cutaneous melanoma to cancer registries in the United States. J Am Acad Dermatol 2003; 49: 624 -30.
15. Koh HK, Clapp RW, Barnett JM, et al. Systemic underreporting of cutaneous malignant melanoma in Massachusetts. Possible implications for national incidence figures. J Am Acad Dermatol 1991; 24: 545 -50.
16. Hagströmer L, Ye W, Nyrén O, Emtestam L,. Incidence of cancer among patients with atopic dermatitis. Arch Dermatol 2005; 141: 1123 -7.
17. Olesen AB, Engholm G, Storm HH, Thestrup-Pedersen K,. The risk of cancer among patients previously hospitalized for atopic dermatitis. J Invest Dermatol 2005; 125: 445 -9.
18. Zhang Y, Holford TR, Leaderer B, et al. Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States women. Cancer Causes Control 2004; 15: 419 -28.
19. Doody MM, Linet MS, Glass AG, et al. Leukemia, lymphoma, and multiple myeloma following selected medical conditions. Cancer Causes Control 1992; 3: 449 -56.
20. Cartwright RA, McKinney PA, OBrien C, et al. Non-Hodgkins lymphoma: case control epidemiological study in Yorkshire. Leuk Res 1988; 12: 81 -8.
21. Bernstein L, Ronald RK,. Prior medication use and health history as risk factors for non-Hodgkins lymphoma: preliminary results from a case-control study in Los Angeles County. Cancer Res 1992; 52: S5510 -15.
22. Fabbro-Peray P, Daures JP, Rossi JF,. Environmental risk factors for non-Hodgkins lymphoma: a population-based case-control study in Languedoc-Roussillon, France. Cancer Causes Control 2001; 12: 201 -12.
23. Milan T, Verkasalo PK, Kaprio J, Koskenvuo M,. Lifestyle differences in twin pairs discordant for basal cell carcinoma of the skin. Br J Dermatol 2003; 149: 115 -23.
24. Naylor M, Elmets C, Jaracz E, Rico JM,. Non-melanoma skin cancer in patients with atopic dermatitis treated with topical tacrolimus. J Dermatolog Treat 2005; 16: 149 -53.
25. Margolis DJ, Hoffstad O, Bilker W,. Lack of association between exposure to topical calcineurin inhibitors and skin cancer in adults. Dermatology 2007; 214: 289 -95.
26. Schrijvers CTM, Stronks K, Van De Mheen DH, et al. Validation of cancer prevalence data from a postal survey by comparison with cancer registry records. Am J Epidemiol 1994; 139: 408 -14.
27. Broberg A, Augustsson A,. Atopic dermatitis and melanocytic naevi. Br J Dermatol 2000; 142: 306 -9.
28. Synnerstad I, Nilsson L, Fredrikson F, Rosdahl I,. Fewer melanocytic nevi found in children with active atopic dermatitis than in children without dermatitis. Arch Dermatol 2004; 140: 1471 -5.
29. Kölmel KF, Compagnone D,. Melanom und Atopie. Dtsch Med Wochenschr 1988; 113: 169 -71.
30. Meal A, Leonardi-Bee J, Smith C, et al. Validation of THIN data for non-melanoma skin cancer. Qual Prim Care 2008; 16: 49 -52.
31. Arellano FM, Wentworth CEW, Arana A, et al. Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis. J Invest Dermatol 2007; 127: 808 -16.
32. Arellano FM, Arana A, Wentworth CEW, et al. Lymphoma among patients with atopic dermatitis and/or treated with topical immunosuppressants in the United Kingdom. J Allergy Clin Immunol 2009; 123: 1111 -16.